https://www.news-medical.net/news/20240108/Nirmatrelvir-treatment-shows-no-link-to-reduced-long-COVID-risk-study-reveals.aspx
Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.
Create an account or login to join the discussion